Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 34.39% is 578% above its 5-year average of 5.08%, near the high end of its 5-year range (0.42%–34.39%).
As of the fiscal period ended Tuesday, June 30, 2026. 172.42% above its 12-month average of 12.62%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 34.39%.
DEBT TO ASSETS RATIO
34.39%
DEBT TO ASSETS RATIO AVG TTM
12.62%
DEBT TO ASSETS RATIO AVG 3Y
7.06%
DEBT TO ASSETS RATIO AVG 5Y
5.08%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+172.42%
CURRENT VS 3Y AVG
+386.95%
CURRENT VS 5Y AVG
+577.56%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 846 covered companies
CURRENT VS SECTOR MEDIAN
+38110.36%
vs the sector median at left
Pulsenmore Ltd. Ordinary Shares
Market Cap
$14.14M
Debt to Assets Ratio
34.39%
TTM Avg
12.62%
3Y Avg
7.06%
5Y Avg
5.08%
Market Cap
$14.21M
Debt to Assets Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.76M
Debt to Assets Ratio
0.29%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.62M
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.62M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.51M
Debt to Assets Ratio
0.20%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.91M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.16M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pulsenmore Ltd. Ordinary Shares (PLSM) | $14.14M | 34.39% | 12.62% | 7.06% | 5.08% |
| Obsidian Therapeutics Inc. (OBX)vs › | $14.21M | N/A | N/A | N/A | N/A |
| Sintx Technologies, Inc. (SINT)vs › | $13.76M | 0.29% | N/A | N/A | N/A |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.62M | 0.05% | N/A | N/A | N/A |
| Vyome Holdings, Inc. (HIND)vs › | $13.62M | 0.00% | N/A | N/A | N/A |
| Optimi Health Corp. (OPTH)vs › | $13.51M | 0.20% | N/A | N/A | N/A |
| Pasithea Therapeutics Corp. (KTTA)vs › | $14.91M | 0.00% | N/A | N/A | N/A |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $13.16M | 0.01% | N/A | N/A | N/A |
| IN8bio, Inc. (INAB)vs › | $13.14M | 0.10% | N/A | N/A | N/A |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.24M | 0.29% | N/A | N/A | N/A |
Debt/Assets
34.4%
Debt/Equity
0.71
Current Ratio
1.84
Interest Coverage
-38.6x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 34.39% |
| 2025-12-31 | 1.54% |
| 2025-06-30 | 1.95% |
| 2024-12-31 | 2.28% |
| 2024-06-30 | 3.06% |
| 2023-12-31 | 3.19% |
| 2023-06-30 | 3.03% |
| 2022-12-31 | 2.99% |
| 2022-06-30 | 2.38% |
| 2021-12-31 | 0.61% |
| 2021-06-30 | 0.42% |
